Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Feneley

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Journal of the Royal Society of Medicine|March 24, 2000
Evaluating the return of prostatic adenocarcinomaM G Berry, M R Feneley, P Domizio, et al.
Journal of Clinical Pathology|September 1, 1996
Ki-67 expression in early prostate cancer and associated pathological lesionsM R Feneley, M P Young, C Chinyama, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 31, 2010
Palliation of male genital cancersC J Shukla, M Shabbir, M R Feneley, et al.
British Journal of Urology|July 1, 1994
Screening for carcinoma of the prostate: a GP based studyR S Kirby, M G Kirby, M R Feneley, et al.
Cancer Surveys|January 1, 1995
Screening in general practiceM R Feneley, M G Kirby, T McNicholas, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
A prospective randomized trial evaluating tissue effects of finasteride therapy in benign prostatic hyperplasiaM R Feneley, P N Span, J A Schalken, et al.
British Journal of Urology|May 1, 1995
Zonal biochemical and morphological characteristics in BPHM R Feneley, J R Puddefoot, S Xia, et al.
Urology|November 9, 2000
Today men with prostate cancer have larger prostatesM R Feneley, P Landis, I Simon, et al.
Human Gene Therapy|August 17, 2001
Transduction and apoptosis induction in the rat prostate, using adenovirus vectorsW Kirkman, P Chen, R Schroeder, et al.
The Journal of Urology|February 26, 1999
Selectivity of finasteride as an in vivo inhibitor of 5alpha-reductase isozyme enzymatic activity in the human prostateP N Span, M C Völler, A G Smals, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Journal of the Royal Society of Medicine|March 24, 2000
Evaluating the return of prostatic adenocarcinomaM G Berry, M R Feneley, P Domizio, et al.
Journal of Clinical Pathology|September 1, 1996
Ki-67 expression in early prostate cancer and associated pathological lesionsM R Feneley, M P Young, C Chinyama, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 31, 2010
Palliation of male genital cancersC J Shukla, M Shabbir, M R Feneley, et al.
British Journal of Urology|July 1, 1994
Screening for carcinoma of the prostate: a GP based studyR S Kirby, M G Kirby, M R Feneley, et al.
Cancer Surveys|January 1, 1995
Screening in general practiceM R Feneley, M G Kirby, T McNicholas, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
A prospective randomized trial evaluating tissue effects of finasteride therapy in benign prostatic hyperplasiaM R Feneley, P N Span, J A Schalken, et al.
British Journal of Urology|May 1, 1995
Zonal biochemical and morphological characteristics in BPHM R Feneley, J R Puddefoot, S Xia, et al.
Urology|November 9, 2000
Today men with prostate cancer have larger prostatesM R Feneley, P Landis, I Simon, et al.
Human Gene Therapy|August 17, 2001
Transduction and apoptosis induction in the rat prostate, using adenovirus vectorsW Kirkman, P Chen, R Schroeder, et al.
The Journal of Urology|February 26, 1999
Selectivity of finasteride as an in vivo inhibitor of 5alpha-reductase isozyme enzymatic activity in the human prostateP N Span, M C Völler, A G Smals, et al.
Pageof 5